Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Trastuzumab Neoadjuvant Therapy in Low HER2 Breast Cancer
NCT00944047Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Jul 2009
- Primary completion
- May 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in Invasive breast cancer (IBC), sponsored by University of Kansas Medical Center. Started Jul 2009; status: completed.
02
Drugs
03
Conditions
Invasive breast cancer (IBC)
Beyond the preview
Go deeper on NCT00944047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944047.